In pancreatic cancer, KDM4B regulates the expression of ZEB1 during TGF-β–induced epithelial-to-mesenchymal transition (EMT), and its silencing significantly impairs cancer cell migration, invasion, and EMT [82]. Here, KDM4B is linked to cancer.